Trade Amgen ^AMGN

Amgen's Repatha reduces heart attack risk in real-world study

57 ETFs Add to Amgen (AMGN) Holdings on Wednesday

While biotech bets swing on trial data, this dividend payer gained 72% since 2024

Boston Trust Walden Corp Sells 15,695 Shares of Amgen Inc. $AMGN

Missed Out On Amgen's Run? Here's The Bet Holders Made - Simply Wall St News

Leerink Partners Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price

Promising Biotech Stocks To Watch Now - November 5th - Markets Daily

Amgen's Real-World Data Shows Repatha Outperforms Ezetimibe For Heart Disease

2,553 Amgen Inc. $AMGN Shares Sold by Kelleher Financial Advisors

Amgen (NASDAQ:AMGN) Stock Price Target Raised at Truist Financial

Amgen (NASDAQ:AMGN) Price Target Raised to $435.00 - Daily Political

Amgen Inc. $AMGN Shares Sold by AIA Group Ltd

2,369 Shares of Amgen Inc. $AMGN Bought by First Nebraska Trust Co

Amgen Inc. $AMGN Stock: Kelleher Financial Advisors Reduces Holdings - Daily Political

Amgen (NASDAQ:AMGN) Given New $530.00 Price Target at UBS Group

Scotiabank Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price

Amgen (NASDAQ:AMGN) Price Target Raised to $465.00 - Markets Daily

Amgen (NASDAQ:AMGN) Given New $425.00 Price Target at JPMorgan Chase & Co.

Amgen earnings analysis: questions answered and next catalysts

Amgen (NASDAQ:AMGN) Price Target Raised to $410.00

Biotech Stocks To Keep An Eye On - November 4th - Markets Daily

Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test

Amgen (NASDAQ:AMGN) Given New $465.00 Price Target at Citigroup - Stock Observer

Truist Financial Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock

Amgen (NASDAQ:AMGN) Reaches New 1-Year High on Strong Earnings - Markets Daily

Stock Market Today: Dow Eyes 2% Jump as AMD Earnings Ease AI Spending Fears

Amgen (NASDAQ:AMGN) Given New $536.00 Price Target at The Goldman Sachs Group - Stock Observer

Generate Biomedicines (NASDAQ:GENB) and CytomX Therapeutics (NASDAQ:CTMX) Critical Contrast - Daily Political

Amgen (NASDAQ:AMGN) Stock Gets Price Target Bump from Cantor Fitzgerald

How Investors May Respond To Amgen (AMGN) Earnings Beat

Rakuten Investment Management Inc. Purchases New Holdings in Amgen Inc. $AMGN

Amgen Inc. $AMGN Stock: Provenance Wealth Advisors LLC Increases Holdings

Amgen Inc. $AMGN Stock Sold by Torray Investment Partners LLC

Sen. Sheldon Whitehouse Unloads Shares of Amgen Inc. (NASDAQ:AMGN) - Markets Daily

Amgen (NASDAQ:AMGN) Sets New 1-Year High After Better-Than-Expected Earnings - Stock Observer

Amgen Inc. $AMGN Stock Position Lessened by Hikari Power Ltd

8,450 Amgen Inc. $AMGN Shares Sold by Factory Mutual Insurance Co.

Hikari Power Ltd Sells 7,000 Shares of Amgen Inc. $AMGN

Amgen (NASDAQ:AMGN) Stock Sale Reported by Sen. Sheldon Whitehouse

Amgen Reports Strong Q3 Earnings, but Share Price Declines Amid Patent Expirations and Competition, ETPharma

Microsoft (NASDAQ:MSFT) Stock Sale Revealed by Sen. Sheldon Whitehouse - Daily Political

Amgen's Portfolio Is Diversifying and Growing, Supporting a Wide Moat Regardless of Maritide Data | Morningstar

Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates

Amgen beats estimates but shares dip on biosimilar concerns

Amgen (NASDAQ:AMGN) Announces Quarterly Earnings Results

Amgen Raises Outlook After 3Q Profit, Sales Rise | Morningstar

Amgen Inc. Q3 Profit Climbs

What Amgen (AMGN) Said on Its Q3 Earnings Call - Stock Observer

Amgen News | Markets Insider

Spdr Dow Jones Industrial Avg ETF (DIA) Sells Goldman Sachs and Caterpillar on Oct. 30

Amgen Inc. $AMGN Shares Purchased by Bank Julius Baer & Co. Ltd Zurich

7,470 Amgen Inc. $AMGN Shares Sold by Hennessy Advisors Inc. - Daily Political

Reply to: 'Interpreting surgical consolidation in oligometastatic gastro-oesophageal cancer'

Will These 5 Drug Bigwigs Surpass Q3 Earnings Forecasts?

RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines

Amgen (AMGN) Gets FDA Warning Letter Over Misleading Vectibix Promotion

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year. Where Does the Target Go Now? - 24/7 Wall St.

Amgen Inc. $AMGN Stock Holdings Raised by MGO One Seven LLC

Amgen (AMGN) Could Be 29% Overvalued Following Encouraging Phase 3 Trial Data

Amgen Inc. $AMGN Shares Acquired by MGO One Seven LLC - Stock Observer

38,406 Shares in Amgen Inc. $AMGN Acquired by Vise Technologies Inc. - Daily Political

Stocktwits Pharma Pulse: Biotech Beats The Broader Market - Novo, Pfizer And Moderna Earnings Up Next

Vertex Pharmaceuticals News | Markets Insider

Denosumab in multiple myeloma patients with severe renal impairment: a multicenter phase 2 study

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

Amgen Inc. $AMGN Stock: Sumitomo Mitsui Trust Group Inc. Lowers Position

Mirae Asset Global Investments Co. Ltd. Purchases New Stake in Amgen Inc. $AMGN

Amgen Inc. $AMGN Stock Bought by ProShare Advisors LLC

Amgen Inc. $AMGN Stock: Raleigh Capital Management Inc. Trims Holdings

Amgen Inc. $AMGN Shares Purchased by Summit Global Investments - Stock Observer

How Positive Trial Results At Amgen (AMGN) Have Changed Its Investment Story

Amgen Inc. $AMGN Stock: ProShare Advisors LLC Boosts Stake - Daily Political

4,920 Amgen Inc. $AMGN Shares Bought by VIRGINIA RETIREMENT SYSTEMS ET Al

Amgen Inc. $AMGN Stock Acquired by International Assets Investment Management LLC - Stock Observer

Amgen (AMGN) Gets A Fresh Look As Phase 3 Wins Meet A Pricey Narrative

New CFO Appointment Could Be A Big Moment For Mattel (MAT)

Amgen (AMGN) Stock Could Trade At A Discount To Cash Flow

Top Biotech Stocks To Follow Today - October 29th - Stock Observer

Clinics: Biontech, Genmab ADCs hit PFS for breast, ovarian cancer

How to Build $6,800 a Month in Dividend Income Without Selling a Single Share

What SPDR Dow Jones Industrial Avg ETF (DIA) Sold: Goldman Leads on Oct. 28

Amgen Inc. $AMGN Shares Acquired by VestGen Advisors LLC

United Asset Strategies Inc. Sells 1,385 Shares of Amgen Inc. $AMGN - Daily Political

2,578 Amgen Inc. $AMGN Shares Acquired by Soltis Investment Advisors LLC - Daily Political

3 Dividend Stocks With Yields Over 2%

Neuroendocrine Prostate Cancer Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | ABNewswire

What SPDR Dow Jones Industrial Avg ETF (DIA) Sold: Goldman Leads on Oct. 27